VHRT and head and neck squamous cell carcinoma: Using fold change > 3 and p < 0.01 as cutoffs, a marked difference in expression was found for MASCC1 between metastatic (lymph node-positive, LN+) and non-metastatic (lymph node-negative, LN−) HNSCC (Figure 1A,B, Table S3).